Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer/Boehringer Spiriva Launched At 30% Discount To Advair For COPD

Executive Summary

Pfizer and Boehringer Ingelheim are launching the chronic obstructive pulmonary disease therapy Spiriva at a 30% discount to the average wholesale price of GlaxoSmithKline's Advair
Advertisement

Related Content

Medi-Span’s Price Alert (correction)
Medi-Span’s Price Alert (correction)
Pfizer/Boehringer Spiriva Clears FDA For COPD; Launch Set For Summer
Pfizer/Boehringer Spiriva Clears FDA For COPD; Launch Set For Summer
GSK Flovent/Advair Diskus Needs More COPD Data; Serevent Cleared For COPD
Advertisement
UsernamePublicRestriction

Register

PS044082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel